nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—Docetaxel—EGFR—pharynx cancer	0.0546	1	CrCbGaD
Paclitaxel—BCL2—mouth—pharynx cancer	0.0249	0.0361	CbGeAlD
Paclitaxel—BCL2—neck—pharynx cancer	0.0213	0.0309	CbGeAlD
Paclitaxel—MAP2—neck—pharynx cancer	0.0185	0.0267	CbGeAlD
Paclitaxel—MAP4—brainstem—pharynx cancer	0.0179	0.0259	CbGeAlD
Paclitaxel—NR1I2—head—pharynx cancer	0.0151	0.0219	CbGeAlD
Paclitaxel—MAP2—parotid gland—pharynx cancer	0.015	0.0218	CbGeAlD
Paclitaxel—TUBB8—head—pharynx cancer	0.0145	0.021	CbGeAlD
Paclitaxel—BCL2—epithelium—pharynx cancer	0.0145	0.021	CbGeAlD
Paclitaxel—MAP2—saliva-secreting gland—pharynx cancer	0.0144	0.0209	CbGeAlD
Paclitaxel—MAPT—spinal cord—pharynx cancer	0.0142	0.0205	CbGeAlD
Paclitaxel—MAP2—brainstem—pharynx cancer	0.0141	0.0204	CbGeAlD
Paclitaxel—MAP4—lymphoid tissue—pharynx cancer	0.0123	0.0178	CbGeAlD
Paclitaxel—TUBB3—lymphoid tissue—pharynx cancer	0.0123	0.0178	CbGeAlD
Paclitaxel—MAPT—Signaling mediated by p38-gamma and p38-delta—CCND1—pharynx cancer	0.0122	0.0478	CbGpPWpGaD
Paclitaxel—TUBB2B—parotid gland—pharynx cancer	0.0112	0.0163	CbGeAlD
Paclitaxel—BCL2—lymphoid tissue—pharynx cancer	0.0112	0.0162	CbGeAlD
Paclitaxel—MAP4—spinal cord—pharynx cancer	0.0111	0.0161	CbGeAlD
Paclitaxel—MAP2—trachea—pharynx cancer	0.0111	0.0161	CbGeAlD
Paclitaxel—TUBB4A—brainstem—pharynx cancer	0.0109	0.0158	CbGeAlD
Paclitaxel—TUBB2B—saliva-secreting gland—pharynx cancer	0.0108	0.0156	CbGeAlD
Paclitaxel—TUBB—parotid gland—pharynx cancer	0.0106	0.0154	CbGeAlD
Paclitaxel—TUBB2A—parotid gland—pharynx cancer	0.0106	0.0153	CbGeAlD
Paclitaxel—TUBB6—parotid gland—pharynx cancer	0.0104	0.0151	CbGeAlD
Paclitaxel—TUBB—saliva-secreting gland—pharynx cancer	0.0102	0.0147	CbGeAlD
Paclitaxel—TUBB2A—saliva-secreting gland—pharynx cancer	0.0101	0.0147	CbGeAlD
Paclitaxel—TUBB6—saliva-secreting gland—pharynx cancer	0.00999	0.0145	CbGeAlD
Paclitaxel—TUBB3—head—pharynx cancer	0.00991	0.0143	CbGeAlD
Paclitaxel—MAP4—head—pharynx cancer	0.00991	0.0143	CbGeAlD
Paclitaxel—TUBB1—head—pharynx cancer	0.00969	0.014	CbGeAlD
Paclitaxel—ABCC10—parotid gland—pharynx cancer	0.00913	0.0132	CbGeAlD
Paclitaxel—TUBB4B—parotid gland—pharynx cancer	0.00907	0.0131	CbGeAlD
Paclitaxel—BCL2—head—pharynx cancer	0.009	0.013	CbGeAlD
Paclitaxel—MAPT—lymph node—pharynx cancer	0.00882	0.0128	CbGeAlD
Paclitaxel—MAP2—spinal cord—pharynx cancer	0.00878	0.0127	CbGeAlD
Paclitaxel—ABCC10—saliva-secreting gland—pharynx cancer	0.00875	0.0127	CbGeAlD
Paclitaxel—TUBB6—epithelium—pharynx cancer	0.00872	0.0126	CbGeAlD
Paclitaxel—TUBB4B—saliva-secreting gland—pharynx cancer	0.00869	0.0126	CbGeAlD
Paclitaxel—TUBB2B—trachea—pharynx cancer	0.0083	0.012	CbGeAlD
Paclitaxel—TUBB—trachea—pharynx cancer	0.00786	0.0114	CbGeAlD
Paclitaxel—TUBB2A—trachea—pharynx cancer	0.00781	0.0113	CbGeAlD
Paclitaxel—MAP2—head—pharynx cancer	0.0078	0.0113	CbGeAlD
Paclitaxel—TUBB6—trachea—pharynx cancer	0.00771	0.0112	CbGeAlD
Paclitaxel—TUBB4A—lymphoid tissue—pharynx cancer	0.00748	0.0108	CbGeAlD
Paclitaxel—TUBB8—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.00716	0.0281	CbGpPWpGaD
Paclitaxel—MAP4—lymph node—pharynx cancer	0.00694	0.01	CbGeAlD
Paclitaxel—TUBB4A—spinal cord—pharynx cancer	0.00678	0.00982	CbGeAlD
Paclitaxel—ABCC10—trachea—pharynx cancer	0.00675	0.00977	CbGeAlD
Paclitaxel—TUBB6—lymphoid tissue—pharynx cancer	0.00671	0.00971	CbGeAlD
Paclitaxel—TUBB4B—trachea—pharynx cancer	0.0067	0.0097	CbGeAlD
Paclitaxel—TUBB2B—spinal cord—pharynx cancer	0.00656	0.00949	CbGeAlD
Paclitaxel—ABCC1—parotid gland—pharynx cancer	0.00646	0.00935	CbGeAlD
Paclitaxel—BCL2—lymph node—pharynx cancer	0.00631	0.00912	CbGeAlD
Paclitaxel—TUBB—spinal cord—pharynx cancer	0.0062	0.00898	CbGeAlD
Paclitaxel—TUBB2A—spinal cord—pharynx cancer	0.00617	0.00893	CbGeAlD
Paclitaxel—TUBB6—spinal cord—pharynx cancer	0.00609	0.00881	CbGeAlD
Paclitaxel—MAPT—Apoptotic cleavage of cellular proteins—CDH1—pharynx cancer	0.00605	0.0238	CbGpPWpGaD
Paclitaxel—TUBB4A—head—pharynx cancer	0.00603	0.00872	CbGeAlD
Paclitaxel—ABCC10—lymphoid tissue—pharynx cancer	0.00588	0.00851	CbGeAlD
Paclitaxel—TUBB4B—lymphoid tissue—pharynx cancer	0.00584	0.00844	CbGeAlD
Paclitaxel—TUBB2B—head—pharynx cancer	0.00583	0.00843	CbGeAlD
Paclitaxel—TUBB2A—head—pharynx cancer	0.00548	0.00794	CbGeAlD
Paclitaxel—MAP2—lymph node—pharynx cancer	0.00546	0.0079	CbGeAlD
Paclitaxel—TUBB6—head—pharynx cancer	0.00541	0.00783	CbGeAlD
Paclitaxel—ABCG2—parotid gland—pharynx cancer	0.00535	0.00774	CbGeAlD
Paclitaxel—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.00534	0.021	CbGpPWpGaD
Paclitaxel—ABCC10—spinal cord—pharynx cancer	0.00533	0.00771	CbGeAlD
Paclitaxel—TUBB4B—spinal cord—pharynx cancer	0.00529	0.00766	CbGeAlD
Paclitaxel—CYP19A1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00515	0.0203	CbGpPWpGaD
Paclitaxel—ABCG2—saliva-secreting gland—pharynx cancer	0.00512	0.00741	CbGeAlD
Paclitaxel—CYP1B1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00496	0.0195	CbGpPWpGaD
Paclitaxel—MAP2—LKB1 signaling events—TP53—pharynx cancer	0.0048	0.0189	CbGpPWpGaD
Paclitaxel—ABCC1—trachea—pharynx cancer	0.00477	0.00691	CbGeAlD
Paclitaxel—MAPT—Apoptotic execution phase—CDH1—pharynx cancer	0.00471	0.0185	CbGpPWpGaD
Paclitaxel—TUBB4B—head—pharynx cancer	0.0047	0.0068	CbGeAlD
Paclitaxel—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.00468	0.0184	CbGpPWpGaD
Paclitaxel—CYP1B1—lymphoid tissue—pharynx cancer	0.00462	0.00669	CbGeAlD
Paclitaxel—CYP19A1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00452	0.0178	CbGpPWpGaD
Paclitaxel—CYP3A7—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00448	0.0176	CbGpPWpGaD
Paclitaxel—CYP1B1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00435	0.0171	CbGpPWpGaD
Paclitaxel—TUBB4A—lymph node—pharynx cancer	0.00422	0.00611	CbGeAlD
Paclitaxel—TUBB2B—lymph node—pharynx cancer	0.00408	0.0059	CbGeAlD
Paclitaxel—CYP19A1—head—pharynx cancer	0.00398	0.00577	CbGeAlD
Paclitaxel—CYP3A7—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00393	0.0154	CbGpPWpGaD
Paclitaxel—TUBB—lymph node—pharynx cancer	0.00386	0.00559	CbGeAlD
Paclitaxel—TUBB2A—lymph node—pharynx cancer	0.00384	0.00556	CbGeAlD
Paclitaxel—TUBB6—lymph node—pharynx cancer	0.00379	0.00548	CbGeAlD
Paclitaxel—CYP1B1—head—pharynx cancer	0.00372	0.00539	CbGeAlD
Paclitaxel—TUBB2B—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.00362	0.0142	CbGpPWpGaD
Paclitaxel—TUBB6—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.00362	0.0142	CbGpPWpGaD
Paclitaxel—TUBB—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.00359	0.0141	CbGpPWpGaD
Paclitaxel—MAPT—Copper homeostasis—CCND1—pharynx cancer	0.00351	0.0138	CbGpPWpGaD
Paclitaxel—TUBB3—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.00349	0.0137	CbGpPWpGaD
Paclitaxel—TUBB2A—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.00338	0.0133	CbGpPWpGaD
Paclitaxel—ABCC10—lymph node—pharynx cancer	0.00332	0.0048	CbGeAlD
Paclitaxel—TUBB1—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.00331	0.013	CbGpPWpGaD
Paclitaxel—TUBB4B—lymph node—pharynx cancer	0.00329	0.00476	CbGeAlD
Paclitaxel—CYP3A5—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00324	0.0127	CbGpPWpGaD
Paclitaxel—BCL2—TP53 Network—TP53—pharynx cancer	0.00318	0.0125	CbGpPWpGaD
Paclitaxel—ABCC2—NRF2 pathway—ADH7—pharynx cancer	0.00314	0.0124	CbGpPWpGaD
Paclitaxel—ABCG2—spinal cord—pharynx cancer	0.00312	0.00452	CbGeAlD
Paclitaxel—MAPT—Notch Signaling Pathway—CCND1—pharynx cancer	0.00309	0.0121	CbGpPWpGaD
Paclitaxel—CYP19A1—Biological oxidations—CNDP2—pharynx cancer	0.00303	0.0119	CbGpPWpGaD
Paclitaxel—TUBB4A—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.00297	0.0117	CbGpPWpGaD
Paclitaxel—CYP1B1—Biological oxidations—CNDP2—pharynx cancer	0.00292	0.0115	CbGpPWpGaD
Paclitaxel—CYP3A5—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00284	0.0112	CbGpPWpGaD
Paclitaxel—CYP2C8—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0028	0.011	CbGpPWpGaD
Paclitaxel—CYP19A1—lymph node—pharynx cancer	0.00279	0.00404	CbGeAlD
Paclitaxel—CYP19A1—Biological oxidations—ADH7—pharynx cancer	0.00274	0.0108	CbGpPWpGaD
Paclitaxel—TUBB4B—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.00272	0.0107	CbGpPWpGaD
Paclitaxel—MAPT—LKB1 signaling events—TP53—pharynx cancer	0.00269	0.0106	CbGpPWpGaD
Paclitaxel—ABCC2—lymph node—pharynx cancer	0.00266	0.00385	CbGeAlD
Paclitaxel—CYP1B1—Biological oxidations—ADH7—pharynx cancer	0.00264	0.0104	CbGpPWpGaD
Paclitaxel—CYP3A7—Biological oxidations—CNDP2—pharynx cancer	0.00263	0.0103	CbGpPWpGaD
Paclitaxel—CYP1B1—lymph node—pharynx cancer	0.00261	0.00377	CbGeAlD
Paclitaxel—BCL2—Activation of BH3-only proteins—TP53—pharynx cancer	0.00255	0.01	CbGpPWpGaD
Paclitaxel—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00246	0.00966	CbGpPWpGaD
Paclitaxel—CYP19A1—Biological oxidations—ADH1B—pharynx cancer	0.0024	0.00944	CbGpPWpGaD
Paclitaxel—CYP3A7—Biological oxidations—ADH7—pharynx cancer	0.00238	0.00935	CbGpPWpGaD
Paclitaxel—ABCC1—lymph node—pharynx cancer	0.00235	0.00339	CbGeAlD
Paclitaxel—MAPT—LPA receptor mediated events—EGFR—pharynx cancer	0.00233	0.00917	CbGpPWpGaD
Paclitaxel—CYP1B1—Biological oxidations—ADH1B—pharynx cancer	0.00231	0.00909	CbGpPWpGaD
Paclitaxel—MAPT—Copper homeostasis—TP53—pharynx cancer	0.00231	0.00909	CbGpPWpGaD
Paclitaxel—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00228	0.00897	CbGpPWpGaD
Paclitaxel—ABCB1—epithelium—pharynx cancer	0.0022	0.00319	CbGeAlD
Paclitaxel—TUBB2A—Signaling events mediated by HDAC Class III—TP53—pharynx cancer	0.00219	0.0086	CbGpPWpGaD
Paclitaxel—CYP3A7—Biological oxidations—ADH1B—pharynx cancer	0.00209	0.0082	CbGpPWpGaD
Paclitaxel—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.002	0.00786	CbGpPWpGaD
Paclitaxel—MAPT—Apoptosis—CDH1—pharynx cancer	0.00196	0.00772	CbGpPWpGaD
Paclitaxel—BCL2—ATF-2 transcription factor network—CCND1—pharynx cancer	0.00195	0.00767	CbGpPWpGaD
Paclitaxel—ABCB1—trachea—pharynx cancer	0.00195	0.00282	CbGeAlD
Paclitaxel—ABCG2—lymph node—pharynx cancer	0.00194	0.00281	CbGeAlD
Paclitaxel—CYP3A5—Biological oxidations—CNDP2—pharynx cancer	0.0019	0.00747	CbGpPWpGaD
Paclitaxel—BCL2—Validated targets of C-MYC transcriptional repression—CCND1—pharynx cancer	0.00185	0.00728	CbGpPWpGaD
Paclitaxel—BCL2—Intrinsic Pathway for Apoptosis—TP53—pharynx cancer	0.00183	0.00718	CbGpPWpGaD
Paclitaxel—BCL2—Amyotrophic lateral sclerosis (ALS)—TP53—pharynx cancer	0.00183	0.00718	CbGpPWpGaD
Paclitaxel—CYP3A5—Biological oxidations—ADH7—pharynx cancer	0.00172	0.00676	CbGpPWpGaD
Paclitaxel—ABCB1—lymphoid tissue—pharynx cancer	0.0017	0.00246	CbGeAlD
Paclitaxel—MAPT—Alzheimers Disease—TP53—pharynx cancer	0.00165	0.0065	CbGpPWpGaD
Paclitaxel—CYP2C8—Biological oxidations—CNDP2—pharynx cancer	0.00165	0.00647	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Cancer Pathway—TP53—pharynx cancer	0.00162	0.00639	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—B4GALT5—pharynx cancer	0.00158	0.00621	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—B4GALT5—pharynx cancer	0.00158	0.00621	CbGpPWpGaD
Paclitaxel—ABCB1—spinal cord—pharynx cancer	0.00154	0.00223	CbGeAlD
Paclitaxel—TUBB3—Metabolism of proteins—B4GALT5—pharynx cancer	0.00153	0.006	CbGpPWpGaD
Paclitaxel—CYP3A5—Biological oxidations—ADH1B—pharynx cancer	0.00151	0.00592	CbGpPWpGaD
Paclitaxel—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0015	0.00591	CbGpPWpGaD
Paclitaxel—CYP2C8—Biological oxidations—ADH7—pharynx cancer	0.00149	0.00585	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—B4GALT5—pharynx cancer	0.00148	0.00581	CbGpPWpGaD
Paclitaxel—BCL2—C-MYB transcription factor network—CCND1—pharynx cancer	0.00147	0.00578	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—B4GALT5—pharynx cancer	0.00145	0.00568	CbGpPWpGaD
Paclitaxel—ABCB1—head—pharynx cancer	0.00137	0.00198	CbGeAlD
Paclitaxel—CYP2C9—Biological oxidations—CNDP2—pharynx cancer	0.00134	0.00527	CbGpPWpGaD
Paclitaxel—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00132	0.00519	CbGpPWpGaD
Paclitaxel—CYP2C8—Biological oxidations—ADH1B—pharynx cancer	0.00131	0.00513	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—B4GALT5—pharynx cancer	0.0013	0.0051	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00124	0.00487	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—CDH1—pharynx cancer	0.00123	0.00485	CbGpPWpGaD
Paclitaxel—CYP2C9—Biological oxidations—ADH7—pharynx cancer	0.00121	0.00476	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—CDH1—pharynx cancer	0.00121	0.00475	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—CCND1—pharynx cancer	0.00119	0.00469	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—B4GALT5—pharynx cancer	0.00119	0.00467	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00113	0.00445	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00113	0.00445	CbGpPWpGaD
Paclitaxel—ABCG2—Fluoropyrimidine Activity—TP53—pharynx cancer	0.00113	0.00444	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—EGFR—pharynx cancer	0.00108	0.00424	CbGpPWpGaD
Paclitaxel—CYP2C9—Biological oxidations—ADH1B—pharynx cancer	0.00106	0.00418	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000972	0.00382	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TP53—pharynx cancer	0.000968	0.00381	CbGpPWpGaD
Paclitaxel—MAPT—Apoptosis—TP53—pharynx cancer	0.000965	0.00379	CbGpPWpGaD
Paclitaxel—ABCB1—lymph node—pharynx cancer	0.000958	0.00139	CbGeAlD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	0.00092	0.00362	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis Modulation and Signaling—TP53—pharynx cancer	0.000908	0.00357	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—TP53—pharynx cancer	0.000905	0.00356	CbGpPWpGaD
Paclitaxel—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.000884	0.00347	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000816	0.00321	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—TP53—pharynx cancer	0.00081	0.00318	CbGpPWpGaD
Paclitaxel—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.000799	0.00314	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—TP53—pharynx cancer	0.000786	0.00309	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—CDH1—pharynx cancer	0.000777	0.00306	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—EGFR—pharynx cancer	0.000767	0.00301	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—CCND1—pharynx cancer	0.000765	0.00301	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000762	0.003	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—CNDP2—pharynx cancer	0.000729	0.00287	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	0.000722	0.00284	CbGpPWpGaD
Paclitaxel—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.000701	0.00275	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—CNDP2—pharynx cancer	0.000686	0.0027	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—ADH7—pharynx cancer	0.000659	0.00259	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—TP53—pharynx cancer	0.000644	0.00253	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—ADH7—pharynx cancer	0.000621	0.00244	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—TP53—pharynx cancer	0.000606	0.00238	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—EGFR—pharynx cancer	0.0006	0.00236	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000598	0.00235	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TP53—pharynx cancer	0.000593	0.00233	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	0.000579	0.00228	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—ADH1B—pharynx cancer	0.000578	0.00227	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—B4GALT5—pharynx cancer	0.000553	0.00217	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—ADH1B—pharynx cancer	0.000544	0.00214	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—B4GALT5—pharynx cancer	0.00052	0.00204	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CNDP2—pharynx cancer	0.000518	0.00204	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CNDP2—pharynx cancer	0.000516	0.00203	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000502	0.00197	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CNDP2—pharynx cancer	0.000499	0.00196	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle, Mitotic—CCND1—pharynx cancer	0.000478	0.00188	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ADH7—pharynx cancer	0.000468	0.00184	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—B4GALT5—pharynx cancer	0.000467	0.00183	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ADH7—pharynx cancer	0.000466	0.00183	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	0.000455	0.00179	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CNDP2—pharynx cancer	0.000454	0.00178	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ADH7—pharynx cancer	0.000451	0.00177	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CNDP2—pharynx cancer	0.00045	0.00177	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD79A—pharynx cancer	0.000441	0.00174	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—CCND1—pharynx cancer	0.000427	0.00168	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ADH1B—pharynx cancer	0.000411	0.00161	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ADH7—pharynx cancer	0.00041	0.00161	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ADH1B—pharynx cancer	0.000409	0.00161	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ADH7—pharynx cancer	0.000407	0.0016	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—CCND1—pharynx cancer	0.000396	0.00156	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ADH1B—pharynx cancer	0.000395	0.00155	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—B4GALT5—pharynx cancer	0.000392	0.00154	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—B4GALT5—pharynx cancer	0.000391	0.00154	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—TP53—pharynx cancer	0.000382	0.0015	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—B4GALT5—pharynx cancer	0.000378	0.00149	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—CCND1—pharynx cancer	0.000362	0.00142	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ADH1B—pharynx cancer	0.00036	0.00141	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ADH1B—pharynx cancer	0.000357	0.0014	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—CCND1—pharynx cancer	0.000354	0.00139	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—B4GALT5—pharynx cancer	0.000344	0.00135	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—B4GALT5—pharynx cancer	0.000341	0.00134	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CNDP2—pharynx cancer	0.000325	0.00128	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—CCND1—pharynx cancer	0.000324	0.00127	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ADH7—pharynx cancer	0.000294	0.00116	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—TP53—pharynx cancer	0.000282	0.00111	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CNDP2—pharynx cancer	0.000282	0.00111	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ADH1B—pharynx cancer	0.000258	0.00101	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ADH7—pharynx cancer	0.000255	0.001	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—EGFR—pharynx cancer	0.000247	0.000971	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—B4GALT5—pharynx cancer	0.000246	0.000968	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CDH1—pharynx cancer	0.000246	0.000967	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CNDP2—pharynx cancer	0.000245	0.000964	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—TP53—pharynx cancer	0.000233	0.000917	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CNDP2—pharynx cancer	0.000229	0.000901	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000227	0.000894	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ADH1B—pharynx cancer	0.000223	0.000878	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ADH7—pharynx cancer	0.000222	0.000872	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—TP53—pharynx cancer	0.000213	0.000839	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—B4GALT5—pharynx cancer	0.000213	0.000839	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ADH7—pharynx cancer	0.000207	0.000815	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ADH1B—pharynx cancer	0.000194	0.000765	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—B4GALT5—pharynx cancer	0.000186	0.000731	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ADH1B—pharynx cancer	0.000182	0.000714	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000178	0.000701	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—B4GALT5—pharynx cancer	0.000174	0.000683	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.000151	0.000594	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.00015	0.000589	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—EGFR—pharynx cancer	0.000144	0.000565	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000137	0.000537	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.00012	0.000471	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.000115	0.00045	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EGFR—pharynx cancer	8.33e-05	0.000327	CbGpPWpGaD
